Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to presentation in conjunction with Acroud's third quarter of 2022

On Thursday 10[th] November at 08:00 a.m. CET Acroud's interim report for the third quarter of 2022 will be published. At 10:00 a.m. CET the same day, a presentation of Acroud's interim report for the third quarter of 2022 will be presented.CEO Robert Andersson and CFO Roderick Attard will present the report, followed by a Q&A session. The presentation will be held in English and will be webcasted live through www.acroud.com or via https://tv.streamfabriken.com/acroud-q3-2022.   To join the conference via phone, please dial-in using any of the numbers below:From Sweden: +46856642692

Interim Report of KONE Corporation for January–September 2022

KONE Corporation, stock exchange release, October 27, 2022 at 12.30 p.m. EEST Interim Report of KONE Corporation for January–September 2022 Strong development in Services, New Equipment business burdened by China July–September 2022 · Orders received declined by 2.5% to EUR 2,155.5 (7–9/2021: 2,211.1) million. At comparable exchange rates, orders declined by 10.0%. · Sales grew by 14.9% to EUR 2,998.2 (2,610.0) million. At comparable exchange rates, sales grew by 6.5%. · Operating income (EBIT) was EUR 303.9 (326.5) million or 10.1% (12.5%) of sales. The adjusted EBIT

Rightbridge Ventures Group AB determines the record date for the consolidation of shares

At an extraordinary general meeting on September 29, 2022 in Rightbridge Ventures Group AB ("Rightbridge" or the "Company"), it was decided to merge the Company's shares through a so-called reverse split, meaning that twenty-five (25) existing shares are merged into one (1) share. The consolidation concerned the Company's ordinary shares, which are subject to trading on the Nasdaq First North Growth Market. The meeting authorizes the board to determine the record date for the consolidation. The company's board has today, with the support of this authorization, decided on the record date for

Metsä Group’s comparable operating result in January–September 2022 was EUR 966 million

Metsä Group press release 27 October 2022January–September 2022 (1–9/2021) · Sales were EUR 5,239 million (4,457). · Operating result was EUR 986 million (652). Comparable operating result was EUR 966 million (694). · Result before taxes was EUR 961 million (616). Comparable result before taxes was EUR 934 million (658). · Comparable return on capital employed was 20.0% (16.4). · Net cash flow from operations was EUR 828 million (596). July–September 2022 (7–9/2021) · Sales were EUR 1,823 million (1,515). · Operating result was EUR 397 million (273). Comparable

Artificial Solutions appoints Patrik Rosenberg as EMEA Vice President

Artificial Solutions ® (SSME:ASAI ), a leading specialist in Conversational AI (CAI), today announces that it has appointed Patrik Rosenberg  as Vice President, Sales, EMEA.Rosenberg will be responsible for EMEA growth and developing Artificial Solutions’ footprint across Europe, while building new and stronger relationships with partners. He will focus on high-growth markets, such as the UK – where Artificial Solutions

Metsä Board’s comparable operating result in 2022 January–September was EUR 420 million

Metsä Board Corporation Interim report January–September 27 October 2022 at 12:00 noon EETJanuary–September 2022 (compared to 1–9/2021) · Sales were EUR 1,879.7 million (1,565.6). · The comparable operating result was EUR 420.0 million (295.3), or 22.3% of sales (18.9). Operating result was EUR 436.8 million (285.0). · Comparable earnings per share were EUR 0.90 (0.65), and earnings per share were EUR 0.94 (0.63). · Comparable return on capital employed was 23.0% (19.4). · Net cash flow from operations was EUR 161.7 million (209.8). July–September 2022 (compared to 7–9/

Tug of the year – powered by Echandia

The world’s first all-electric ship-handling tug Sparky – wins the prestigious ‘Tug of the Year award’ at the 2022 International Tug & Salvage Awards in Istanbul, Turkey. The impressively powerful and emission-free tug, that operates on Echandia’s LTO batteries, has a 70-ton bollard pull that will stack up with the performance of any conventional tug.Most ship-handling harbor tugs operate under harsh conditions and are set to take on heavy-duty jobs. Thus, tugboats running on lithium batteries might seem like an exceptionally difficult proposition. However, since August 2022, Sparky – the

Finnish customer in the public sector places order worth MSEK 2,4 on Advenica’s Cross Domain Solutions- products and services

Advenica, the Swedish supplier of cybersecurity solutions, has received an order from a Finnish customer in the public sector. The order is worth MSEK 2,4 and concerns Cross Domain Solutions - products and services.Advenica provides expertise and world-class high assurance cybersecurity solutions for critical information up to Top Secret classification. With these solutions countries, authorities and companies can raise information security and digitalize in a responsible way. Cross Domain Solutions enable strictly controlled and filtered information exchange between domains with different

Go Mate Partners with Challengermode to Host Call of Duty: Warzone 2.0 Launch Day Esports Tournaments

Stockholm. October 27th 2022: Natural smart drinks company Go Mate has partnered with international esports platform Challengermode for a series of launch day esports tournaments for Call of Duty: Warzone 2.0. This partnership builds on the existing work that Challengermode has done with Go Mate to promote its healthy energy drink alternatives to an international audience of grassroots esports competitors.Coinciding with the release of Call of Duty: Warzone 2.0, Go Mate will officially be launching its line of all-natural smart drinks aimed at the gaming and esports community. Starting the

Brain+ adds new clinical and development competencies to accelerate and support market access of its digital dementia product portfolio

Copenhagen, Denmark, October 27, 2022 – Brain+ A/S (Nasdaq First North: BRAINP) · Rising star clinical dementia researcher to join the company in a new position as Clinical Director · Recently, development was also strengthened with a Quality Manager and a Clinical Research Associate · The new hires represent a significant competence upgrade and expansion of the clinical team for a more efficient product development and commercializationBrain+ (BRAINP), a pioneer in the development of digital therapeutics for Alzheimer’s disease and dementia, has hired Nahid Zokaei to a new

Salmon Evolution ASA: Notice of Extraordinary General Meeting

Reference is made to the stock exchange notice by Salmon Evolution ASA (the "Company") on 25 October 2022 regarding the proposal from the Company’s nomination committee that Håkon André Berg is appointed as board member. The Company hereby calls for an extraordinary general meeting (the "EGM") in the Company to be held on Friday 18 November 2022 at 11:00 CET, where the election of Håkon André Berg to the Board of Directors of the Company is on the agenda. Please find attached the following documents: · Notice of the EGM · Proxy form · The Board of Directors' proposed

Hilti’s Nuron offering supports Red Bull in Swiss dam scaling challenge

Red Bull’s 2022 Dual Ascent challenge has this year been supported by Hilti, with the global construction brand providing all anchors and tools to create a challenging dam climbing route for some of the world’s bravest adventurists.Taking place at Verzasca Dam in Switzerland from October 26[th] to the 29[th], the Red Bull Dual Ascent is a man-made solution to outdoor climbing competitions, which are often difficult to organise due to real-world conditions and variables with the route, logistics and impact on the environment. Standing at 220m high, the jaw-droppingly impressive Verzasca

Getinge expands its Virtual Hospital to add more value for visitors

Since the opening in 2021, Getinge’s Virtual Hospital has offered visitors to experience hospital solutions in different rooms. The online facility is now coming together as a whole, with entire hospital departments allowing visitors the full picture of how the MedTech suppliers broad range of solutions work together throughout the clinical pathway. “A new Central Sterile Supply Department (CSSD) shows how we can help customers develop a streamlined and cost-effective process, from the moment the instruments have been used, to the moment when they are ready to be used again,” says

Solteq Plc’s Financial Reporting and Annual General Meeting in 2023

Stock Exchange Bulletin, October 27, 2022 at 11:00 a.m.Solteq Plc publishes the following financial reports during 2023:Financial Statements Bulletin 2022 – February 16, 2023, 8.00 a.m. EETInterim Report 1–3/2023 – May 4, 2023, 8.00 a.m. EETHalf-Year Financial Report 1–6/2023 – August 23, 2023, 8.00 a.m. EETInterim Report 1-9/2023 – October 26, 2023, 8.00 a.m. EET The Annual Report for 2022, including Report of the Board of Directors and Financial Statements, will be published on Solteq’s website by March 7, 2023. The Annual General Meeting is planned to be held in Vantaa on

IFS continues to deliver strong 2022 financial performance with Q3 Year-to-Date results

· Annual Recurring Revenue increases by 38% YoY · Cloud Revenue grows at 104% Vs. 2021 Q3 YTD · Third consecutive high performance quarter cements IFS leadership in core capabilitiesLondon, UK, October 27, 2022 – IFS , the global cloud enterprise software company, today reported its financial results for Q3 year-to-date (YTD) ending September 30, 2022. IFS posted strong financial performance with Annual Recurring Revenue (ARR) increasing by 38 percent year on year (YOY) and cloud revenue growth of 104 percent Vs. 2021 Q3 YTD. The company attributes its continued

Zalaris to deliver outsourced payroll services based on PeopleHub to Amplifon Deutschland GmbH

Reference is made to the announcement on 7th of September regarding the signing of an agreement with an international retailer in Germany.Zalaris, the provider of payroll  and HR solutions  that simplify work life and support creating sustainable businesses, today announced the signing of an agreement with Amplifon Deutschland GmbH  to provide outsourced payroll services in Germany.  Amplifon Deutschland GmbH, based in Hamburg, is part of the Amplifon Group, global leader in the hearing care

Invitation to telephone conference for Interim Report 1 January - 30 September 2022

MEKO's Interim Report for the third quarter 2022 will be published on Wednesday 2 November at 07:30 a.m CET. A webcast/telephone conference will be held the same day at 09:00 a.m in English. MEKO's President and CEO Pehr Oscarson and CFO Åsa Källenius will present the results and respond to questions. The presentation material will be available from 8:00 a.m CEST on 2 November, at www.meko.com under the heading Investors/IR-presentations . Follow the presentation live via meko.com/webcast 

ABAX partner, Greater Than, acknowledged as one of the most innovative InsurTech companies in 2022.

FinTech Global have revealed the 100 companies of innovators that will transform the global insurance industry. ABAX AI-partner, Greater Than is listed for the third time and ABAX is proud to be this year’s case study as proof for future innovation. FinTech Global and its industry experts have selected the 100 companies worldwide that they find the most innovative in the industry. The panel of industry experts and analysts have looked over the full list of over 1400 companies and recognized the 100 most innovative businesses using technology as their main tool to solve an industry

Read original

BioStock: Sprint Bioscience focuses on developing internal programs and partnering

When research company Sprint Bioscience publishes its report for the third quarter, the focus is on development of the internal pharmaceutical programs and new partnerships. The company had a busy schedule at BioEurope, which took place this week in Leipzig, Germany, and it continued to see great interest in the VADA and DISA programs. BioStock talked to CEO Erik Kinnman about partnerships, the upcoming rights issue and what lies ahead.Read the full article about the Sprint Biosciences latest quarter at biostock.se/en: https://www.biostock.se/en/2022/10/sprint-bioscience-focuses-on-

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 221 - 27 OCTOBER 2022 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

Digital and group-based lifestyle counselling to prevent type 2 diabetes shows real-world effectiveness in Finnish health care

People’s diet quality improved and their abdominal obesity and insulin resistance decreased in a one-year lifestyle intervention, new findings from the Finnish StopDia study show. Looking at 2,907 Finnish adults with an elevated risk for type 2 diabetes, the study is the first to examine the effects of a group-based lifestyle intervention implemented in primary health care on risk factors for type 2 diabetes. The lifestyle intervention made use of a digital app and multiple behaviour change theories. The findings were published in The Lancet Regional Health – Europe.The StopDia approach was

Outokumpu completed the change negotiations related to the restriction of the ferrochrome production

Outokumpu OyjPress releaseOctober 27, 2022 at 10.30 am EESTOutokumpu completed the change negotiations related to the restriction of the ferrochrome production Outokumpu has completed its change negotiations related to the company's plans to further restrict the ferrochrome production and to delay the restart of one ferrochrome furnace after a maintenance break at least until the end of the first quarter of 2023. At the start of the negotiations, Outokumpu announced that the planned measures would concern at most 70 people. The aim in the change negotiations was to find a solution

Chairman declines re-election in Sleep Cycle

October 27, 2022, Gothenburg – The chairman of the board of directors in Sleep Cycle AB, Lars Berg, has today informed the nomination committee that he declines re-election at the 2023 annual general meeting.“It has been a lovely assignment being the chairman in Sleep Cycle, a company with high growth, good profitability, and strong cash generation. When I accepted the role as chairman I promised the owners to lead the work of the board of directors through the IPO and a few years thereafter. My assignment is therefore coming to an end, and it is a natural time to let someone else take over

Muvon Therapeutics announces First Patient Enrolled in Phase II Clinical Study in Female Patients with Stress Urinary Incontinence using Novel Regenerative Cell Therapy

Zurich, Switzerland, October 27, 2022 – Muvon Therapeutics AG, an innovative clinical-stage biotechnology company, today announced that the first patient with Stress Urinary Incontinence has been enrolled as part of the planned Phase II clinical trial (SUISSE MPC 2-Study) using its novel proprietary cell therapy platform.   This is a randomized blinded clinical study, evaluating the safety and efficacy of a low and high dose of autologous skeletal muscle precursor cell injections into the urethral sphincter muscle of women living with stress urinary incontinence (SUI) with the

There are no items matching the current filter
There are no more items matching the current filter
Back to top